BGI Australia opened a laboratory in May 2017 which is also BGI’s first genomics laboratory located in the southern hemisphere. The laboratory hosts BGI’s proprietary sequencing platform including BGISEQ-500 (Zebra) and MGISEQ-2000 (Panda), which have also received CFDA (China Food and Drug Administration) certification recently in July 2018. The state of the art facility currently has the capacity to sequence approximately 1,800 Whole genome sequencing samples or about 40,000 RNA-seq samples per year and is anticipating the addition of more sequencers to double the throughput. Since the debut BGI Australia Laboratory focuses on serving for diverse local research collaborations, e.g. sequencing samples for RNA-seq, Whole Genome Sequencing, Exome, ChiP-seq and Methyl-seq applications.